Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection

New England Journal of Medicine

Volumn 347, Issue 2, 2002, Pages 89-94

  Hermine, Olivier ^a   Lefrère, François ^a   Bronowicki, Jean Pierre ^b   Mariette, Xavier ^c   Jondeau, Katayoun ^d   Eclache Saudreau, Virginie ^e   Delmas, Béatrice ^f   Valensi, Françoise ^a   Cacoub, Patrice ^g   Brechot, Christian ⁱ   Varet, Bruno ^a   Troussard, Xavier ^h  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b UNIVERSITY HOSPITAL OF NANCY   (France)

^c BICÊTRE HOSPITAL   (France)

^d Hôpital Cochin ^*  (France)

^e HÔPITAL JEAN VERDIER   (France)

^f HÔPITAL PAUL BROUSSE   (France)

^g PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^h CHU CÔTE DE NACRE   (France)

ⁱ NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON; RIBAVIRIN; VIRUS RNA;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CANCER REGRESSION; CLINICAL ARTICLE; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DRUG EFFECT; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LYMPHOMA; MALE; PRIORITY JOURNAL; REMISSION; SPLEEN LYMPHOMA; TREATMENT OUTCOME; VIRUS LOAD;

ADULT; AGED; ANTIVIRAL AGENTS; FEMALE; HEPACIVIRUS; HEPATITIS C; HUMANS; INTERFERON-ALPHA; LYMPHOCYTES; LYMPHOMA, B-CELL; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; REMISSION INDUCTION; RNA, VIRAL; SPLENIC NEOPLASMS;

EID: 0037063113     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMoa013376     Document Type: Article

References (29)

1. Isolation of a CDNA clone derived from a blood-borne non-A non-B viral hepatitis genome
2. Prevalence of hepatitis C virus infections in patients with lymphoproliferative disorders
3. Hepatitis C virus infection in patients with B-cell non-Hodgkin lymphoma
4. B cell malignancy and hepatitis C virus infection
5. Cellular origin of human B-cell lymphomas
6. Low-grade malignant lymphoma hepatitis C virus infection and mixed cryoglobulinemia
7. Detection of occult low-grade B-cell non Hodgkin's lymphoma in patient with chronic hepatitis C virus infection and mixed cryoglobulinemia
8. Somatic hypermutation, clonal diversity and preferential expression of the VH 51pl/VL kv325 immunoglobulin gene combination in hepatitis C virus associated immunocytomas
9. Clinico-pathological characterization of hepatitis C virus-related B-cell non-Hodgkin's lymphomas without symptomatic cryoglobulinemia
10. Hepatitis C virus infection in non-Hodgkin's lymphoma
11. No association between hepatitis C and B-cell lymphoma
12. HCV and HGV in B-cell lymphoma
13. Non-Hodgkin's lymphoma and hepatitis C virus infection
14. Hepatitis C virus infection in patients with overt B-cell non-Hodgkin's lymphoma in a French center
15. Splenic lymphoma with villous lymphocytes: Clinical presentation, biology and prognostic factors in a series of 100 patients
16. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee meeting - Airlie House, Virginia, November 1997
17. Characterization of cryoglobulins by immunoblotting
18. Fludarabine: An effective treatment in patients with splenic lymphoma with villous lymphocytes
19. The effect of antiviral therapy on t(14;18) translocation and immunoglobulin gene rearrangement in patients with chronic hepatitis C virus infection
20. Helicobacter pylori associated gastritis and primary B-cell gastric lymphoma
21. V(H)1-69 gene is preferentially used by hepatitis C virus-associated B cell lymphomas and by normal B cells responding to the E2 viral antigen
22. The B-cell receptor of a hepatitis C virus (HCV)-associated non-Hodgkin lymphoma binds the viral E2 envelope protein, implicating HCV in lymphomagenesis
23. Marginal-zone B cells in the human lymph node and spleen show somatic hypermutations and display clonal expansion
24. Sequence analysis of the immunoglobulin antigen receptor of hepatitis C virus-associated non-Hodgkin lymphoma suggests that the malignant cells are derived from the rheumatoid factor-producing cells that occur mainly in type II cryoglobulinemia
25. Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor
26. Binding of hepatitis C virus to CD81
27. Hepatitis C virus nonstructural protein NS3 transforms NIH3T3 cells
28. Hepatitis C virus core protein cooperates with ras and transforms primary rat embryo fibroblast to tumorigenic phenotype
29. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice